190 related articles for article (PubMed ID: 37290053)
1. A Recombinant Vesicular Stomatitis Virus-Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection.
Woolsey C; Strampe J; Fenton KA; Agans KN; Martinez J; Borisevich V; Dobias NS; Deer DJ; Geisbert JB; Cross RW; Connor JH; Geisbert TW
J Infect Dis; 2023 Nov; 228(Suppl 7):S712-S720. PubMed ID: 37290053
[TBL] [Abstract][Full Text] [Related]
2. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
Woolsey C; Borisevich V; Agans KN; O'Toole R; Fenton KA; Harrison MB; Prasad AN; Deer DJ; Gerardi C; Morrison N; Cross RW; Eldridge JH; Matassov D; Geisbert TW
J Infect Dis; 2023 Nov; 228(Suppl 7):S660-S670. PubMed ID: 37171813
[TBL] [Abstract][Full Text] [Related]
3. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVΔG-ZEBOV-GP).
Raabe V; Lai L; Morales J; Xu Y; Rouphael N; Davey RT; Mulligan MJ
Vaccine; 2023 Feb; 41(8):1513-1523. PubMed ID: 36725433
[TBL] [Abstract][Full Text] [Related]
5. Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
Mire CE; Geisbert JB; Marzi A; Agans KN; Feldmann H; Geisbert TW
PLoS Negl Trop Dis; 2013; 7(12):e2600. PubMed ID: 24367715
[TBL] [Abstract][Full Text] [Related]
6.
Woolsey C; Borisevich V; Agans KN; Fenton KA; Cross RW; Geisbert TW
mBio; 2021 Aug; 12(4):e0151721. PubMed ID: 34372693
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Vesicular Stomatitis Virus-Ebola Virus Postexposure Treatment in Rhesus Macaques Infected With Ebola Virus Makona.
Marzi A; Hanley PW; Haddock E; Martellaro C; Kobinger G; Feldmann H
J Infect Dis; 2016 Oct; 214(suppl 3):S360-S366. PubMed ID: 27496978
[TBL] [Abstract][Full Text] [Related]
8. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
[TBL] [Abstract][Full Text] [Related]
9. Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.
Marzi A; Engelmann F; Feldmann F; Haberthur K; Shupert WL; Brining D; Scott DP; Geisbert TW; Kawaoka Y; Katze MG; Feldmann H; Messaoudi I
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1893-8. PubMed ID: 23319647
[TBL] [Abstract][Full Text] [Related]
10. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
[TBL] [Abstract][Full Text] [Related]
11. Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.
Falzarano D; Feldmann F; Grolla A; Leung A; Ebihara H; Strong JE; Marzi A; Takada A; Jones S; Gren J; Geisbert J; Jones SM; Geisbert TW; Feldmann H
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1082-9. PubMed ID: 21987745
[TBL] [Abstract][Full Text] [Related]
12. Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
Mire CE; Miller AD; Carville A; Westmoreland SV; Geisbert JB; Mansfield KG; Feldmann H; Hensley LE; Geisbert TW
PLoS Negl Trop Dis; 2012; 6(3):e1567. PubMed ID: 22448291
[TBL] [Abstract][Full Text] [Related]
13. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
[TBL] [Abstract][Full Text] [Related]
14. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
Woolsey C; Cross RW; Agans KN; Borisevich V; Deer DJ; Geisbert JB; Gerardi C; Latham TE; Fenton KA; Egan MA; Eldridge JH; Geisbert TW; Matassov D
PLoS Negl Trop Dis; 2022 May; 16(5):e0010433. PubMed ID: 35622847
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
Geisbert TW; Feldmann H
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
[TBL] [Abstract][Full Text] [Related]
16. Ferrets Infected with Bundibugyo Virus or Ebola Virus Recapitulate Important Aspects of Human Filovirus Disease.
Kozak R; He S; Kroeker A; de La Vega MA; Audet J; Wong G; Urfano C; Antonation K; Embury-Hyatt C; Kobinger GP; Qiu X
J Virol; 2016 Oct; 90(20):9209-23. PubMed ID: 27489269
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
Front Immunol; 2021; 12():703986. PubMed ID: 34484200
[TBL] [Abstract][Full Text] [Related]
18. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates.
Marzi A; Feldmann F; O'Donnell KL; Hanley PW; Messaoudi I; Feldmann H
J Infect Dis; 2023 Nov; 228(Suppl 7):S671-S676. PubMed ID: 37290042
[TBL] [Abstract][Full Text] [Related]
19. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
20. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
